Results 101 to 110 of about 5,209 (179)

Spatial Multiomics Reveal Insights Into ADC Efficacy. [PDF]

Eur J Immunol
Goni O, Klümper N, Moreno MDMM, Eckstein M, Kuppe C.   +4 more
europepmc   +1 more source

Response to trastuzumab-deruxtecan in metastatic triple-negative breast cancer with both HER2 mutation and low expression. [PDF]

Einstein (Sao Paulo)
Amarger CD, Rabello MIS, Skaf SC, Moura F, Cassoli JPB, Taranto P, Serrano Usón Junior PL, Kaliks R, Beal JR.   +8 more
europepmc   +1 more source

Exploring the Interplay Between Radioimmunoconjugates and Fcγ Receptors in Genetically Engineered Mouse Models of Cancer. [PDF]

ACS Pharmacol Transl Sci
Rodriguez C, Sarrett SM, Sebastiano J, Delaney S, McGlone SA, Hosny MM, Thau S, Bournazos S, Zeglis BM.   +8 more
europepmc   +1 more source

Evaluating Radiotheranostic Targets for Endometrial Cancer. [PDF]

J Nucl Med
Sebastiano J, McGlone SA, Samuels ZV, Grimaldi C, Stoddard A, Galka S, Colaco E, Zeglis BM.   +7 more
europepmc   +1 more source

Neoadjuvant immunotherapy combined with HER2-targeted antibody-drug conjugate in bladder urothelial carcinoma: a case report. [PDF]

BMC Urol
Guo Z, Wang G.
europepmc   +1 more source

FDA and EMA approval of datopotamab-deruxtecan: A paradigm shift in breast cancer drug evaluation? [PDF]

Breast
Orlandi A.
europepmc   +1 more source

Trojan horses at leptomeningeal cellular gates: Antibody-drug conjugates deliver cytotoxic payloads. [PDF]

Med
Nikanjam M, Kurzrock R.
europepmc   +1 more source

Interstitial pneumonitis related to sacituzumab govitecan in a patient with metastatic triple-negative breast cancer: a case report. [PDF]

J Med Case Rep
Lin MC, Lin CW.
europepmc   +1 more source

The future of urothelial carcinoma: a 2024-2025 update of early-phase trials of novel therapeutic agents. [PDF]

Curr Opin Urol
Lee YHA, Wong CM, Liu AQ, Teoh JY.
europepmc   +1 more source

Mass spectrometric imaging and quantitative analysis of the <i>in vivo</i> biodistribution of trastuzumab using a rhodium(iii) sarcophagine complex.

Inorg Chem Front
Patel N, Pham TT, Banu A, Griffiths A, Paterson BM, Firth G, Morrell A, McMahon C, Long NJ, Baker JR, Chudasama V, Ma MT.   +11 more
europepmc   +1 more source